Straits Times Index
3,330.01 -8.93 (-0.27%) S&P 500
5,354.03 +62.69 (+1.18%) Dow
38,807.33 +96.04 (+0.25%) Nasdaq
17,187.90 +330.86 (+1.96%) Bitcoin USD
71,103.43 +526.53 (+0.75%) CMC Crypto 200
1,517.11 +43.37 (+2.94%)
ACB Sep 2024 13.000 call
| Previous close | 0.6000 |
| Open | 0.6000 |
| Bid | 0.0000 |
| Ask | 0.5100 |
| Strike | 13.00 |
| Expiry date | 2024-09-20 |
| Day's range | 0.6000 - 0.6000 |
| Contract range | N/A |
| Volume | |
| Open interest | 44 |
PR NewswireAurora Unveils Premium Resin Cartridges in Australia
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) – the Canadian based leading global medical cannabis company, in conjunction with MedReleaf Australia, is excited to announce the launch of its premium 1.2g resin cartridges in Australia. This expansion marks a significant step in Aurora's mission to provide high-quality products to patients worldwide. Now available for doctors to prescribe to patients in Australia, Aurora's new resign cartridges, developed and manufactured at the company's EU-GMP an
ZacksSol-Gel Technologies Ltd. (SLGL) Reports Q1 Loss, Lags Revenue Estimates
SolGel Technologies (SLGL) delivered earnings and revenue surprises of -53.33% and 64.15%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
ZacksStrength Seen in Canopy Growth (CGC): Can Its 11.0% Jump Turn into More Strength?
Canopy Growth (CGC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
